Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade

Additional Information

GBI Research, the leading business intelligence provider, has released its latest research “Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment per Trial has Continued to Decline Over the Past Decade” which provides an insight into clinical trial and patient recruitment in Autoimmune Disorders. The report examines different aspects under clinical trial and patient recruitment. The report analyzes the number of clinical trials and the number of patients recruited for five major indications such as Multiple Sclerosis, Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis and Psoriasis. It provides information about the total number of clinical trials conducted, by stage of development, geography, major sponsors and trials conducted per year. Analysis on the total number of patients recruited and the average number of patients recruited per each trial is also provided. The report analyzes total number of patients recruited by stage of development, geography, major sponsors and trails conducted per year from 2000 to 2009. The average number of patients recruited by stage of development per year is also covered. For Brazil, China and India, an estimate of prevalence population has also been provided for the years 2010 to 2017 across the five major autoimmune disorders.

The Number of Clinical Trials Conducted for Rheumatoid Arthritis was the Highest of all the Autoimmune Disorders

Clinical Trial Recruitment in Autoimmune Disorders, Total Number of Clinical Trials for the 5 Major Indications, 2000-2009

Source: GBI Research, ClinicalTrials.gov

Rheumatoid Arthritis recorded 230 clinical trials for the period 2000 to 2009 followed by Multiple Sclerosis which recorded 93 clinical trials.

Rheumatoid Arthritis Recorded the Highest Patient Recruitment for the period 2000 to 2009

Clinical Trial Recruitment in Autoimmune Disorders, Total Number of Patients Recruited for the 5 Major Indications, 2000-2009

Source: GBI Research, ClinicalTrials.gov

Rheumatoid Arthritis recorded the highest number of patient recruitment for the period 2000 to 2009 followed by Multiple Sclerosis which recruited 28,423 patients.

Average Patient Recruitment per Trial per Year has Continued to Decline Over the Past Decade, 2000-2009

The average patient recruitment per trial per year has continued to decline over the past decade across the five major indications of autoimmune disorders which are Multiple Sclerosis, Rheumatoid Arthritis, Crohn’s Disease, Ulcerative Colitis and Psoriasis. The average number of patients recruited for clinical trials across five major autoimmune disorders were approximately 408 in 2000. This average had declined to 74 in 2009. In between 2000 and 2009, there is an irregular trend of average patients recruited for clinical trials in five major autoimmune disorders.

The Number of Clinical Trials Conducted in Autoimmune Disorders are Less when compared to Other Therapeutic Areas.

Most number of clinical trials are conducted for central nervous system followed by oncology. 2,298 trials have been conducted for CNS across the globe and 2,044 trials have been conducted for Oncology. The number of clinical trials in autoimmune disorders for the period 2000 to 2009 are less compared to other therapeutic areas. Only 668 trials have been conducted in autoimmune disorders in the period 2000 to 2009.